{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T22:20:00Z","timestamp":1773094800605,"version":"3.50.1"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2015,7,7]],"date-time":"2015-07-07T00:00:00Z","timestamp":1436227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2015,7,7]],"date-time":"2015-07-07T00:00:00Z","timestamp":1436227200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"DOI":"10.1038\/tp.2015.27","type":"journal-article","created":{"date-parts":[[2015,7,7]],"date-time":"2015-07-07T14:00:21Z","timestamp":1436277621000},"page":"e594-e594","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Argon blocks the expression of locomotor sensitization to amphetamine through antagonism at the vesicular monoamine transporter-2 and mu-opioid receptor in the nucleus accumbens"],"prefix":"10.1038","volume":"5","author":[{"given":"H N","family":"David","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Dhilly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Degoulet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G","family":"Poisnel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Meckler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N","family":"Vall\u00e9e","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J-\u00c9","family":"Blatteau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J-J","family":"Risso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Lemaire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Debruyne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J H","family":"Abraini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,7,7]]},"reference":[{"key":"BFtp201527_CR1","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1126\/science.2903550","volume":"242","author":"GF Koob","year":"1988","unstructured":"Koob GF, Bloom FE . Cellular and molecular mechanisms of drug dependence. Science 1988; 242: 715\u2013723.","journal-title":"Science"},{"key":"BFtp201527_CR2","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1146\/annurev.ne.18.030195.002335","volume":"18","author":"DW Self","year":"1995","unstructured":"Self DW, Nestler EJ . Molecular mechanisms of drug reinforcement and addiction. Annu Rev Neurosci 1995; 18: 463\u2013495.","journal-title":"Annu Rev Neurosci"},{"key":"BFtp201527_CR3","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1146\/annurev.ne.19.030196.001535","volume":"19","author":"RA Wise","year":"1996","unstructured":"Wise RA . Addictive drugs and brain stimulation reward. Annu Rev Neurosci 1996; 19: 319\u2013340.","journal-title":"Annu Rev Neurosci"},{"key":"BFtp201527_CR4","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/S0896-6273(00)80111-7","volume":"16","author":"SE Hyman","year":"1996","unstructured":"Hyman SE . Addiction to cocaine and amphetamine. Neuron 1996; 16: 901\u2013904.","journal-title":"Neuron"},{"key":"BFtp201527_CR5","doi-asserted-by":"publisher","first-page":"3312","DOI":"10.1523\/JNEUROSCI.22-09-03312.2002","volume":"22","author":"B Everitt","year":"2002","unstructured":"Everitt B, Wolf ME . Psychomotor stimulant addiction: a neural systems perspective. J Neurosci 2002; 22: 3312\u20133320.","journal-title":"J Neurosci"},{"key":"BFtp201527_CR6","doi-asserted-by":"publisher","first-page":"215","DOI":"10.2174\/157015911795016949","volume":"9","author":"LT Tien","year":"2011","unstructured":"Tien LT, Ho IK . Involvement of \u03bc-opioid receptor in methamphetamine-induced behavioral sensitization. Curr Neuropharmacol 2011; 9: 215\u2013218.","journal-title":"Curr Neuropharmacol"},{"key":"BFtp201527_CR7","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1097\/01.WCB.0000087342.31689.18","volume":"23","author":"HN David","year":"2003","unstructured":"David HN, L\u00e9veill\u00e9 F, Chazalviel L, MacKenzie ET, Buisson A, Lemaire M et al. Reduction of ischemic brain damage by nitrous oxide and xenon. J Cereb Blood Flow Metab 2003; 23: 1168\u20131173.","journal-title":"J Cereb Blood Flow Metab"},{"key":"BFtp201527_CR8","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1096\/fj.07-9420com","volume":"22","author":"HN David","year":"2008","unstructured":"David HN, Haelewyn B, Rouillon C, Lecocq M, Chazalviel L, Apiou G et al. Neuroprotective effects of xenon: a therapeutic window of opportunity in rats subjected to transient cerebral ischemia. FASEB J 2008; 22: 1275\u20131286.","journal-title":"FASEB J"},{"key":"BFtp201527_CR9","doi-asserted-by":"publisher","first-page":"e30934","DOI":"10.1371\/journal.pone.0030934","volume":"7","author":"HN David","year":"2012","unstructured":"David HN, Haelewyn B, Degoulet M, Colomb DG Jr, Risso JJ, Abraini JH . Ex vivo and in vivo neuroprotection induced by argon when given after an excitotoxic or ischemic insult. PLoS One 2012; 7: e30934.","journal-title":"PLoS One"},{"key":"BFtp201527_CR10","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1097\/00000542-200310000-00020","volume":"99","author":"HM Homi","year":"2003","unstructured":"Homi HM, Yokoo N, Ma D, Warner DS, Franks NP, Maze M et al. The neuroprotective effect of xenon administration during transient middle cerebral artery occlusion in mice. Anesthesiology 2003; 99: 876\u2013881.","journal-title":"Anesthesiology"},{"key":"BFtp201527_CR11","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1097\/00000542-200303000-00017","volume":"98","author":"D Ma","year":"2003","unstructured":"Ma D, Yang H, Lynch J, Franks NP, Maze M, Grocott HP . Xenon attenuates cardiopulmonary bypass-induced neurologic and neurocognitive dysfunction in the rat. Anesthesiology 2003; 98: 690\u2013698.","journal-title":"Anesthesiology"},{"key":"BFtp201527_CR12","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1002\/ana.20547","volume":"58","author":"D Ma","year":"2005","unstructured":"Ma D, Hossain M, Chow A, Arshad M, Battson RM, Sanders RD et al. Xenon and hypothermia combine to provide neuroprotection from neonatal asphyxia. Ann Neurol 2005; 58: 182\u2013193.","journal-title":"Ann Neurol"},{"key":"BFtp201527_CR13","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1196\/annals.1344.025","volume":"1053","author":"JH Abraini","year":"2005","unstructured":"Abraini JH, Lemaire M, David HN . Potentially neuroprotective and therapeutic properties of nitrous oxide and xenon. Ann N Y Acad Sci 2005; 1053: 289\u2013300.","journal-title":"Ann N Y Acad Sci"},{"key":"BFtp201527_CR14","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1161\/01.STR.0000198867.31134.ac","volume":"37","author":"J Dingley","year":"2006","unstructured":"Dingley J, Tooley J, Porter H, Thoresen M . Xenon provides short-term neuroprotection in neonatal rats when administered after hypoxia-ischemia. Stroke 2006; 37: 501\u2013506.","journal-title":"Stroke"},{"key":"BFtp201527_CR15","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1097\/CCM.0b013e318183f646","volume":"36","author":"B Haelewyn","year":"2008","unstructured":"Haelewyn B, David HN, Rouillon C, Chazalviel L, Lecocq M, Risso JJ et al. Neuroprotection by nitrous oxide: facts and evidence. Crit Care Med 2008; 36: 2651\u20132659.","journal-title":"Crit Care Med"},{"key":"BFtp201527_CR16","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1213\/01.ane.0000278083.31991.36","volume":"105","author":"PS Pagel","year":"2007","unstructured":"Pagel PS, Krolikowski JG, Shim YH, Venkatapuram S, Kersten JR, Weihrauch D et al. Noble gases without anesthetic properties protect myocardium against infarction by activating prosurvival signalling kinases and inhibiting mitochondrial permeability transition in vivo. Anesth Analg 2007; 105: 562\u2013569.","journal-title":"Anesth Analg"},{"key":"BFtp201527_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.heares.2004.09.015","volume":"201","author":"YM Yarin","year":"2005","unstructured":"Yarin YM, Amarjargal N, Fuchs J, Haupt H, Mazurel B, Morozovan SV et al. Argon protects hypoxia-, cisplatin- and gentamycin-exposed hair cells in the newborn rat\u2019s organ of Corti. Hear Res 2005; 201: 1\u20139.","journal-title":"Hear Res"},{"key":"BFtp201527_CR18","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.neulet.2009.05.069","volume":"460","author":"N Jawad","year":"2009","unstructured":"Jawad N, Rizvi M, Gu J, Adeyi O, Tao G, Maze M et al. Neuroprotection (and lack of neuroprotection) afforded by a series of noble gases in an in vitro model of neuronal injury. Neurosci Lett 2009; 460: 232\u2013236.","journal-title":"Neurosci Lett"},{"key":"BFtp201527_CR19","doi-asserted-by":"publisher","first-page":"R206","DOI":"10.1186\/cc8214","volume":"13","author":"PD Loetscher","year":"2009","unstructured":"Loetscher PD, Rossaint J, Rossaint R, Weis J, Fries M, Fahlenkamp A et al. Argon: Neuroprotection in in vitro models of cerebral ischemia and traumatic brain injury. Critical Care 2009; 13: R206.","journal-title":"Critical Care"},{"key":"BFtp201527_CR20","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1097\/CCM.0b013e3182452164","volume":"40","author":"L Zhuang","year":"2012","unstructured":"Zhuang L, Yang T, Zhao H, Fidalgo AR, Vizcaychipi MP, Sanders RD et al. The protective profile of argon, helium, and xenon in a model of neonatal asphyxia in rats. Crit Care Med 2012; 40: 1724\u20131730.","journal-title":"Crit Care Med"},{"key":"BFtp201527_CR21","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/nm0498-460","volume":"4","author":"V Jevtovic-Todorovic","year":"1998","unstructured":"Jevtovic-Todorovic V, Todorovic SM, Mennerick S, Powell S, Dikranian K, Benshoff N et al. Nitrous oxide (laughing gas) is an NMDA antagonist, neuroprotectant and neurotoxin. Nature Med 1998; 4: 460\u2013463.","journal-title":"Nature Med"},{"key":"BFtp201527_CR22","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1038\/24525","volume":"396","author":"NP Franks","year":"1998","unstructured":"Franks NP, Dickinson R, de Sousa SLM, Hall AC, Lieb WR . How does xenon produce anesthesia? Nature 1998; 396: 324.","journal-title":"Nature"},{"key":"BFtp201527_CR23","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1097\/00000542-200010000-00034","volume":"93","author":"T Yamakura","year":"2000","unstructured":"Yamakura T, Harris RA . Effects of gaseous anesthetics nitrous oxide and xenon on ligand-gated ion channels. Comparison with isoflurane and ethanol. Anesthesiology 2000; 93: 1095\u20131101.","journal-title":"Anesthesiology"},{"key":"BFtp201527_CR24","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1124\/jpet.110.177287","volume":"336","author":"NA Northrop","year":"2011","unstructured":"Northrop NA, Smith LP, Yamamoto BK, Eyerman DJ . Regulation of glutamate release by \u03b17 nicotinic receptors: differential role in methamphetamine-induced damage to dopaminergic and serotonergic terminals. J Pharmacol Exp Ther 2011; 336: 900\u2013907.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFtp201527_CR25","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/j.neuropharm.2010.10.003","volume":"60","author":"MN Kim","year":"2011","unstructured":"Kim MN, Jutkiewicz EM, Zhang M, Gnegy ME . The sensitizing effect of acute nicotine on amphetamine-stimulated behavior and dopamine efflux requires activation of \u03b22 subunit-containing nicotinic acetylcholine receptors and glutamate N-methyl-D-aspartate receptors. Neuropharmacology 2011; 60: 1126\u20131134.","journal-title":"Neuropharmacology"},{"key":"BFtp201527_CR26","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1111\/j.1369-1600.2010.00297.x","volume":"18","author":"M Degoulet","year":"2013","unstructured":"Degoulet M, Rostain JC, Abraini JH, David HN . Short-term development of behavioral sensitization to amphetamine requires N-methyl-D-aspartate- and nicotinic-dependent mechanisms in the nucleus accumbens. Addict Biol 2013; 18: 417\u2013424.","journal-title":"Addict Biol"},{"key":"BFtp201527_CR27","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.biopsych.2005.10.007","volume":"60","author":"HN David","year":"2006","unstructured":"David HN, Ansseau M, Lemaire M, Abraini JH . Nitrous oxide and xenon prevent amphetamine-induced carrier-mediated dopamine release in a memantine-like fashion and protect against behavioral sensitization. Biol Psychiatry 2006; 60: 49\u201357.","journal-title":"Biol Psychiatry"},{"key":"BFtp201527_CR28","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1213\/01.ANE.0000050282.14291.38","volume":"96","author":"JH Abraini","year":"2003","unstructured":"Abraini JH, Kriem B, Balon N, Rostain JC, Risso JJ . Gamma-aminobutyric neuropharmacological investigations on narcosis produced by nitrogen, argon, or nitrous oxide. Anesth Analg 2003; 96: 746\u2013749.","journal-title":"Anesth Analg"},{"key":"BFtp201527_CR29","first-page":"135","volume":"74","author":"K Ito","year":"1999","unstructured":"Ito K . The role of gamma-aminobutyric acid (GABA)-benzodiazepine neurotransmission in an animal model of methamphetamine-induced psychosis. Hokkaido Igaku Zasshi 1999; 74: 135\u2013144.","journal-title":"Hokkaido Igaku Zasshi"},{"key":"BFtp201527_CR30","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/S0091-3057(99)00263-4","volume":"65","author":"K Ito","year":"2000","unstructured":"Ito K, Ohmori T, Abekawa T, Koyama T . The role of benzodiazepine receptors in the acquisition and expression of behavioral sensitization to methamphetamine. Pharmacol Biochem Behav 2000; 65: 705\u2013710.","journal-title":"Pharmacol Biochem Behav"},{"key":"BFtp201527_CR31","doi-asserted-by":"crossref","unstructured":"David HN, Dhilly M, Poisnel G, Degoulet M, Meckler C, Vall\u00e9e N et al. Argon prevents the development of locomotor sensitization to amphetamine and amphetamine-induced changes in mu opioid receptor in the nucleus accumbens. Medical Gas Research 2014; 4; doi:10.1186\/s13618-014-0021-z.","DOI":"10.1186\/s13618-014-0021-z"},{"key":"BFtp201527_CR32","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1002\/jnr.22386","volume":"88","author":"X Shen","year":"2010","unstructured":"Shen X, Purser C, Tien LT, Chiu CT, Paul IA, Baker R et al. mu-Opioid receptor knockout mice are insensitive to methamphetamine-induced behavioral sensitization. J Neurosci Res 2010; 88: 2294\u20132302.","journal-title":"J Neurosci Res"},{"key":"BFtp201527_CR33","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1254\/jphs.08249FP","volume":"110","author":"G Poisnel","year":"2009","unstructured":"Poisnel G, Dhilly M, Le Boisselier R, Barre L, Debruyne D . Comparison of five benzodiazepine-receptor agonists on buprenorphine-induced mu-opioid receptor regulation. J Pharmacol Sci 2009; 110: 36\u201346.","journal-title":"J Pharmacol Sci"},{"key":"BFtp201527_CR34","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1038\/jcbfm.2009.275","volume":"30","author":"HN David","year":"2010","unstructured":"David HN, Haelewyn B, Risso JJ, Colloc\u2019h N, Abraini JH . Xenon is an inhibitor of tissue-plasminogen activator: adverse and beneficial effects in a rat model of thromboembolic stroke. J Cereb Blood Flow Metab 2010; 30: 718\u2013728.","journal-title":"J Cereb Blood Flow Metab"},{"key":"BFtp201527_CR35","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s00210-012-0809-0","volume":"386","author":"HN David","year":"2013","unstructured":"David HN, Haelewyn B, Risso JJ, Abraini JH . Modulation by the noble gas argon of the catalytic and thrombolytic efficiency of tissue plasminogen activator. Naunyn Schmiedebergs Arch Pharmacol 2013; 386: 91\u201395.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"BFtp201527_CR36","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1097\/ALN.0b013e3182a2a265","volume":"119","author":"K Harris","year":"2013","unstructured":"Harris K, Armstrong SP, Campos-Pires R, Kiru L, Franks NP, Dickinson R . Neuroprotection against traumatic brain injury by xenon, but not argon, is mediated by inhibition at the N-methyl-D-aspartate receptor glycine site. Anesthesiology 2013; 119: 1137\u20131148.","journal-title":"Anesthesiology"},{"key":"BFtp201527_CR37","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/0006-2952(82)90332-X","volume":"31","author":"NY Liang","year":"1982","unstructured":"Liang NY, Rutledge CO . Comparison of the release of [3H]dopamine from isolated corpus striatum by amphetamine, fenfluramine and unlabelled dopamine. Biochem Pharmacol 1982; 31: 983\u2013992.","journal-title":"Biochem Pharmacol"},{"key":"BFtp201527_CR38","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S0022-3565(25)24727-9","volume":"257","author":"R Zaczek","year":"1991","unstructured":"Zaczek R, Culp S, Goldberg H, Mccann DJ, De Souza EB . Interactions of [3H]amphetamine with rat brain synaptosomes. I. Saturable sequestration. J Pharmacol Exp Ther 1991; 257: 820\u2013829.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFtp201527_CR39","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/S0022-3565(25)24730-9","volume":"257","author":"R Zaczek","year":"1991","unstructured":"Zaczek R, Culp S, De Souza EB . Interactions of [3H]amphetamine with rat brain synaptosomes. II. Active transport. J Pharmacol Exp Ther 1991; 257: 830\u2013835.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFtp201527_CR40","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1016\/0006-2952(82)90057-0","volume":"31","author":"NY Liang","year":"1982","unstructured":"Liang NY, Rutledge CO . Evidence for carrier-mediated efflux of dopamine from corpus striatum. Biochem Pharmacol 1982; 31: 2479\u20132484.","journal-title":"Biochem Pharmacol"},{"key":"BFtp201527_CR41","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1146\/annurev.pa.33.040193.003231","volume":"33","author":"LS Seiden","year":"1993","unstructured":"Seiden LS, Sabol KE, Ricaurte GA . Amphetamine: effects on catecholamine systems and behavior. Annu Rev Pharmacol Toxicol 1993; 33: 639\u2013677.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"BFtp201527_CR42","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/B978-0-12-420118-7.00002-0","volume":"69","author":"JR Nickell","year":"2014","unstructured":"Nickell JR, Siripurapu KB, Vartak A, Crooks PA, Dwoskin LP . The vesicular monoamine transporter-2: an important pharmacological target for the discovery of novel therapeutics to treat methamphetamine abuse. Adv Pharmacol 2014; 69: 71\u2013106.","journal-title":"Adv Pharmacol"},{"key":"BFtp201527_CR43","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1111\/j.1471-4159.1993.tb03181.x","volume":"60","author":"D Sulzer","year":"1993","unstructured":"Sulzer D, Maidment NT, Rayport S . Amphetamine and other weak bases act to promote reverse transport of dopamine in ventral midbrain neurons. J Neurochem 1993; 60: 527\u2013535.","journal-title":"J Neurochem"},{"key":"BFtp201527_CR44","doi-asserted-by":"publisher","first-page":"4102","DOI":"10.1523\/JNEUROSCI.15-05-04102.1995","volume":"15","author":"D Sulzer","year":"1995","unstructured":"Sulzer D, Chen TK, Lau YY, Kristensen H, Rayport S, Ewing A . Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport. J Neurosci 1995; 15: 4102\u20134108.","journal-title":"J Neurosci"},{"key":"BFtp201527_CR45","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1523\/JNEUROSCI.18-06-01979.1998","volume":"18","author":"SR Jones","year":"1998","unstructured":"Jones SR, Gainetdinov RR, Wightman RM, Caron MG . Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter. J Neurosci 1998; 18: 1979\u20131986.","journal-title":"J Neurosci"},{"key":"BFtp201527_CR46","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/0896-6273(90)90339-H","volume":"5","author":"D Sulzer","year":"1990","unstructured":"Sulzer D, Rayport S . Amphetamine and other psychostimulants reduce pH gradients in midbrain dopaminergic neurons and chromaffin granules: a mechanism of action. Neuron 1990; 5: 797\u2013808.","journal-title":"Neuron"},{"key":"BFtp201527_CR47","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1046\/j.1471-4159.1995.64020689.x","volume":"64","author":"E Floor","year":"1995","unstructured":"Floor E, Leventhal PS, Wang Y, Meng L, Chen W . Dynamic storage of dopamine in rat brain synaptic vesicles in vitro. J Neurochem 1995; 64: 689\u2013699.","journal-title":"J Neurochem"},{"key":"BFtp201527_CR48","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S0304-3940(96)12963-3","volume":"215","author":"E Floor","year":"1996","unstructured":"Floor E, Meng L . Amphetamine releases dopamine from synaptic vesicles by dual mechanisms. Neurosci Lett 1996; 215: 53\u201356.","journal-title":"Neurosci Lett"},{"key":"BFtp201527_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF00499868","volume":"310","author":"F Mack","year":"1979","unstructured":"Mack F, Bonisch H . Dissociation constants and lipophilicity of catecholamines and related compounds. Naunyn Schmiedebergs Arch Pharmacol 1979; 310: 1\u20139.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"BFtp201527_CR50","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.1096\/fj.05-1103ufm","volume":"19","author":"AD Bangham","year":"2005","unstructured":"Bangham AD . Liposomes and the physico-chemical basis of unconsciousness. FASEB J 2005; 19: 1766\u20131768.","journal-title":"FASEB J"},{"key":"BFtp201527_CR51","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/nature09647","volume":"469","author":"H Nury","year":"2011","unstructured":"Nury H, Van Renterghem C, Weng Y, Tran A, Baaden M, Dufresne V et al. X-ray structures of general anaesthetics bound to a pentameric ligand-gated ion channel. Nature 2011; 469: 428\u2013431.","journal-title":"Nature"},{"key":"BFtp201527_CR52","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1529\/biophysj.106.093807","volume":"92","author":"N Colloc\u2019h","year":"2007","unstructured":"Colloc\u2019h N, Sopkova-de Oliveira Santos J, Retailleau P, Vivar\u00e8s D, Bonnet\u00e9 F, Langlois d'Estaintot B et al. Protein crystallography under xenon and nitrous oxide pressure: comparison with in vivo pharmacology studies and implications for the mechanism of inhaled anesthetic action. Biophys J 2007; 92: 217\u2013224.","journal-title":"Biophys J"},{"key":"BFtp201527_CR53","first-page":"285","volume-title":"Current Trends in X-ray Crystallography","author":"N Colloc\u2019h","year":"2010","unstructured":"Colloc\u2019h N, Marassio G, Prang\u00e9 T . Protein-noble gas interactions investigated by crystallography on three enzymes. Implication on anesthesia and neuroprotection mechanisms. In: Chandrasekaran A (ed.). Current Trends in X-ray Crystallography. InTech, 2010; 285\u2013308."},{"key":"BFtp201527_CR54","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.1096\/fj.11-183046","volume":"25","author":"G Marassio","year":"2011","unstructured":"Marassio G, Prang\u00e9 T, David HN, Santos JS, Gabison L, Delcroix N et al. Pressure-response analysis of anesthetic gases xenon and nitrous oxide on urate oxidase: a crystallographic study. FASEB J 2011; 25: 2266\u20132275.","journal-title":"FASEB J"},{"key":"BFtp201527_CR55","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1097\/ALN.0000000000000435","volume":"121","author":"JH Abraini","year":"2014","unstructured":"Abraini JH, Marassio G, David HN, Vallone B, Prang\u00e9 T, Colloc\u2019h N . Crystallographic studies with xenon and nitrous oxide provide evidence for protein-dependent processes in the mechanisms of general anesthesia. Anesthesiology 2014; 121: 1018\u20131027.","journal-title":"Anesthesiology"},{"key":"BFtp201527_CR56","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1046\/j.1471-4159.2003.01732.x","volume":"85","author":"J Patel","year":"2003","unstructured":"Patel J, Mooslehner KA, Chan PM, Emson PC, Stamford JA . Presynaptic control of striatal dopamine neurotransmission in adult vesicular monoamine transporter 2 (VMAT2) mutant mice. J Neurochem 2003; 85: 898\u2013910.","journal-title":"J Neurochem"},{"key":"BFtp201527_CR57","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1124\/jpet.104.067314","volume":"310","author":"CJ Wilhelm","year":"2004","unstructured":"Wilhelm CJ, Johnson RA, Lysko PG, Eshleman AJ, Janowsky A . Effects of methamphetamine and lobeline on vesicular monoamine and dopamine transporter-mediated dopamine release in a cotransfected model system. J Pharmacol Exp Ther 2004; 310: 1142\u20131151.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFtp201527_CR58","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1016\/j.bcp.2007.11.019","volume":"75","author":"CJ Wilhelm","year":"2008","unstructured":"Wilhelm CJ, Johnson RA, Eshleman AJ, Janowsky A . Lobeline effects on tonic and methamphetamine-induced dopamine release. Biochem Pharmacol 2008; 75: 1411\u20131415.","journal-title":"Biochem Pharmacol"},{"key":"BFtp201527_CR59","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1124\/jpet.109.160275","volume":"332","author":"JR Nickell","year":"2010","unstructured":"Nickell JR, Krishnamurthy S, Norrholm S, Deaciuc G, Siripurapu KB, Zheng G et al. Lobelane inhibits methamphetamine-evoked dopamine release via inhibition of the vesicular monoamine transporter-2. J Pharmacol Exp Ther 2010; 332: 612\u2013621.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFtp201527_CR60","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1046\/j.1471-4159.1996.67062292.x","volume":"67","author":"CA Schad","year":"1996","unstructured":"Schad CA, Justice JB Jr, Holtzman SG . Differential effects of delta- and mu-opioid receptor antagonists on the amphetamine-induced increase in extracellular dopamine in striatum and nucleus accumbens. J Neurochem 1996; 67: 2292\u20132299.","journal-title":"J Neurochem"},{"key":"BFtp201527_CR61","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1016\/j.neuroscience.2006.05.003","volume":"141","author":"DS Mathon","year":"2006","unstructured":"Mathon DS, Vanderschuren LJ, Ramakers GM . Reduced psychostimulant effects on dopamine dynamics in the nucleus accumbens of mu-opioid receptor knockout mice. Neuroscience 2006; 141: 1679\u20131684.","journal-title":"Neuroscience"},{"key":"BFtp201527_CR62","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s11373-007-9218-7","volume":"15","author":"KC Lan","year":"2008","unstructured":"Lan KC, Ma T, Lin-Shiau SY, Liu SH, Ho IK . Methamphetamine-elicited alterations of dopamine- and serotonin-metabolite levels within mu-opioid receptor knockout mice: a microdialysis study. J Biomed Sci 2008; 15: 391\u2013403.","journal-title":"J Biomed Sci"},{"key":"BFtp201527_CR63","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.drugalcdep.2007.02.003","volume":"89","author":"DK Miller","year":"2007","unstructured":"Miller DK, Lever JR, Rodvelt KR, Baskett JA, Will MJ, Kracke GR . Lobeline, a potential pharmacotherapy for drug addiction, binds to mu opioid receptors and diminishes the effects of opioid receptor agonists. Drug Alcohol Depend 2007; 89: 282\u2013291.","journal-title":"Drug Alcohol Depend"},{"key":"BFtp201527_CR64","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1002\/syn.20913","volume":"65","author":"EF Langsdorf","year":"2011","unstructured":"Langsdorf EF, Chang SL . Methamphetamine-mediated modulation of MOR expression in the SH-SY5Y neuroblastoma cell line. Synapse 2011; 65: 858\u2013865.","journal-title":"Synapse"},{"key":"BFtp201527_CR65","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1007\/s11373-006-9102-x","volume":"13","author":"CT Chiu","year":"2006","unstructured":"Chiu CT, Ma T, Ho IK . Methamphetamine-induced behavioral sensitization in mice: alterations in mu-opioid receptor. J Biomed Sci 2006; 13: 797\u2013811.","journal-title":"J Biomed Sci"},{"key":"BFtp201527_CR66","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1002\/1098-2396(20010301)39:3<239::AID-SYN1005>3.0.CO;2-B","volume":"39","author":"JC Chen","year":"2001","unstructured":"Chen JC, Liang KW, Huang EY . Differential effects of endomorphin-1 and -2 on amphetamine sensitization: neurochemical and behavioral aspects. Synapse 2001; 39: 239\u2013248.","journal-title":"Synapse"},{"key":"BFtp201527_CR67","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.lfs.2006.05.006","volume":"79","author":"JE Polston","year":"2006","unstructured":"Polston JE, Cunningham CS, Rodvelt KR, Miller DK . Lobeline augments and inhibits cocaine-induced hyperactivity in rats. Life Sci 2006; 79: 981\u2013990.","journal-title":"Life Sci"},{"key":"BFtp201527_CR68","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1002\/syn.20726","volume":"64","author":"JH Yoo","year":"2010","unstructured":"Yoo JH, Lee HK, Kim HC, Lee SY, Jang CG . GABA(A) receptors mediate the attenuating effects of a 5-HT(3) receptor antagonist on methamphetamine-induced behavioral sensitization in mice. Synapse 2010; 64: 274\u2013279.","journal-title":"Synapse"},{"key":"BFtp201527_CR69","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.bbrc.2006.10.046","volume":"351","author":"X Zhang","year":"2006","unstructured":"Zhang X, Lee TH, Xiong X, Chen Q, Davidson C, Wetsel WC et al. Methamphetamine induces long-term changes in GABAA receptor alpha2 subunit and GAD67 expression. Biochem Biophys Res Commun 2006; 351: 300\u2013305.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFtp201527_CR70","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1177\/0269881109349837","volume":"25","author":"HC Urschel 3rd","year":"2011","unstructured":"Urschel HC 3rd, Hanselka LL, Baron M . A controlled trial of flumazenil and gabapentin for initial treatment of methylamphetamine dependence. J Psychopharmacol 2011; 25: 254\u2013262.","journal-title":"J Psychopharmacol"},{"key":"BFtp201527_CR71","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.neuro.2011.05.016","volume":"32","author":"L Hondebrink","year":"2011","unstructured":"Hondebrink L, Meulenbelt J, van Kleef RG, van den Berg M, Westerink RH . Modulation of human GABAA receptor function: a novel mode of action of drugs of abuse. Neurotoxicology 2011; 32: 823\u2013827.","journal-title":"Neurotoxicology"},{"key":"BFtp201527_CR72","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.neuro.2012.12.003","volume":"35","author":"L Hondebrink","year":"2013","unstructured":"Hondebrink L, Tan S, Hermans E, van Kleef RG, Meulenbelt J, Westerink RH . Additive inhibition of human \u03b11\u03b22\u03b32 GABAA receptors by mixtures of commonly used drugs of abuse. Neurotoxicology 2013; 35: 23\u201329.","journal-title":"Neurotoxicology"},{"key":"BFtp201527_CR73","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1097\/01.fbp.0000166464.68186.25","volume":"16","author":"MB Gatch","year":"2005","unstructured":"Gatch MB, Selvig M, Forster MJ . GABAergic modulation of the discriminative stimulus effects of methamphetamine. Behav Pharmacol 2005; 16: 261\u2013266.","journal-title":"Behav Pharmacol"},{"key":"BFtp201527_CR74","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.brainres.2004.08.032","volume":"1026","author":"E Khaimova","year":"2004","unstructured":"Khaimova E, Kandov Y, Israel Y, Cataldo G, Hadjimarkou MM, Bodnar RJ . Opioid receptor subtype antagonists differentially alter GABA agonist-induced feeding elicited from either the nucleus accumbens shell or ventral tegmental area regions in rats. Brain Res 2004; 1026: 284\u2013294.","journal-title":"Brain Res"},{"key":"BFtp201527_CR75","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1007\/s11064-007-9373-2","volume":"32","author":"LT Tien","year":"2007","unstructured":"Tien LT, Ma T, Fan LW, Loh HH, Ho IK . Autoradiographic analysis of GABAA receptors in mu-opioid receptor knockout mice. Neurochem Res 2007; 32: 1891\u20131897.","journal-title":"Neurochem Res"},{"key":"BFtp201527_CR76","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1034\/j.1601-183X.2003.00013.x","volume":"2","author":"L Jamot","year":"2003","unstructured":"Jamot L, Matthes HW, Simonin F, Kieffer BL, Roder JC . Differential involvement of the mu and kappa opioid receptors in spatial learning. Genes Brain Behav 2003; 2: 80\u201392.","journal-title":"Genes Brain Behav"},{"key":"BFtp201527_CR77","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/S0169-328X(03)00291-2","volume":"117","author":"CG Jang","year":"2003","unstructured":"Jang CG, Lee SY, Yoo JH, Yan JJ, Song DK, Loh HH et al. Impaired water maze learning performance in mu-opioid receptor knockout mice. Brain Res Mol Brain Res 2003; 117: 68\u201372.","journal-title":"Brain Res Mol Brain Res"},{"key":"BFtp201527_CR78","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S0022-3565(24)29365-4","volume":"298","author":"SB Harrod","year":"2001","unstructured":"Harrod SB, Dwoskin LP, Crooks PA, Klebaur JE, Bardo MT . Lobeline attenuates d-methamphetamine self-administration in rats. J Pharmacol Exp Ther 2001; 298: 172\u2013179.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFtp201527_CR79","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.ejphar.2007.06.003","volume":"571","author":"NM Neugebauer","year":"2007","unstructured":"Neugebauer NM, Harrod SB, Stairs DJ, Crooks PA, Dwoskin LP, Bardo MT . Lobelane decreases methamphetamine self-administration in rats. Eur J Pharmacol 2007; 571: 33\u201338.","journal-title":"Eur J Pharmacol"},{"key":"BFtp201527_CR80","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1177\/0269881108092119","volume":"24","author":"N Hart","year":"2010","unstructured":"Hart N, Rocha A, Miller DK, Nation JR . Dose-dependent attenuation of heroin self-administration with lobeline. J Psychopharmacol 2010; 24: 51\u201355.","journal-title":"J Psychopharmacol"},{"key":"BFtp201527_CR81","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1152\/ajplegacy.1939.126.2.409","volume":"126","author":"AR Behnke","year":"1939","unstructured":"Behnke AR, Yarbrough OD . Respiratory resistance, oil-water solubility, and mental effects of argon, compared with helium and nitrogen. Am J Physiol 1939; 126: 409\u2013415.","journal-title":"Am J Physiol"},{"key":"BFtp201527_CR82","first-page":"1181","volume":"42","author":"KN Ackles","year":"1971","unstructured":"Ackles KN, Fowler B . Cortical evoked response and inert gas narcosis in man. Aerosp Med 1971; 42: 1181\u20131184.","journal-title":"Aerosp Med"},{"key":"BFtp201527_CR83","first-page":"1219","volume":"43","author":"B Fowler","year":"1972","unstructured":"Fowler B, Ackles KN . Narcotic effects in man of breathing 80-20 argon-oxygen and air under hyperbaric conditions. Aerosp Med 1972; 43: 1219\u20131224.","journal-title":"Aerosp Med"},{"key":"BFtp201527_CR84","first-page":"357","volume":"50","author":"DJ Horrigan","year":"1979","unstructured":"Horrigan DJ, Wells CH, Guest MM, Hart GB, Goodpasture JE . Tissue gas and blood analyses of human subjects breathing 80% argon and 20% oxygen. Aviat Space Environ Med 1979; 50: 357\u2013362.","journal-title":"Aviat Space Environ Med"},{"key":"BFtp201527_CR85","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1136\/jnnp.56.9.1035","volume":"56","author":"PM Rothwell","year":"1993","unstructured":"Rothwell PM, Grant R . Cerebral venous sinus thrombosis induced by 'ecstasy'. J Neurol Neurosurg Psychiatry 1993; 56: 1035.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BFtp201527_CR86","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1016\/0002-8703(94)90757-9","volume":"128","author":"TT Bashour","year":"1994","unstructured":"Bashour TT . Acute myocardial infarction resulting from amphetamine abuse: a spasm-thrombus interplay? Am Heart J 1994; 128: 1237\u20131239.","journal-title":"Am Heart J"},{"key":"BFtp201527_CR87","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/0002-9343(94)90087-6","volume":"96","author":"DJ Moliterno","year":"1994","unstructured":"Moliterno DJ, Lange RA, Gerard RD, Willard JE, Lackner C, Hillis LD . Influence of intranasal cocaine on plasma constituents associated with endogenous thrombosis and thrombolysis. Am J Med 1994; 96: 492\u2013496.","journal-title":"Am J Med"},{"key":"BFtp201527_CR88","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.jstrokecerebrovasdis.2007.04.001","volume":"16","author":"DA De Silva","year":"2007","unstructured":"De Silva DA, Wong MC, Lee MP, Chen CL, Chang HM . Amphetamine-associated ischemic stroke: clinical presentation and proposed pathogenesis. J Stroke Cerebrovasc Dis 2007; 16: 185\u2013186.","journal-title":"J Stroke Cerebrovasc Dis"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/tp201527.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/tp201527","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/tp201527.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T02:15:45Z","timestamp":1748484945000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/tp201527"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,7]]},"references-count":88,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2015,7]]}},"alternative-id":["BFtp201527"],"URL":"https:\/\/doi.org\/10.1038\/tp.2015.27","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,7]]},"assertion":[{"value":"29 September 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"HND was a paid scientist at NNOXe Pharmaceuticals, QC, Canada. ML is a medical director at Air Liquide, Paris, France. Both companies, NNOXe Pharmaceuticals (NNX) and Air Liquide (AL), have patents on the use of argon as a medical gas (granted: FR2956323 (AL); pending: FR2996457 (AL), FR3004312 (AL), FR3004350 (AL), GB1310588.7 (NNX)). The remaining authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}